ISSN: 1859 - 2872
Determining the mortality prognostic value of the CURB-65 scale in hospitalized patients with COVID-19 pneumonia
Main Article Content
Keywords
Abstract
Objective: To determine the mortality prognostic value of the CURB-65 scale in hospitalized patients with COVID-19 pneumonia. Subject and method: Prospective study, longitudinal follow-up of 131 patients with COVID-19 pneumonia hospitalized at the COVID Treatment Center of Hospital 175, from July 17, 2021 to October 1, 2021. The CURB-65 score is used to assess the risk of death for hospitalized COVID-19 patients. Result: 131 hospitalized patients with COVID-19 pneumonia were studied, the mean age was 55.57 ± 14.6 years old. 60 male patients (45.8%); 71 female patients (54.2%). The mortality rate gradually increased according to the CURB–65 score (p<0.001). The CURB-65 score had a good predictor of mortality in hospitalized patients with COVID-19 pneumonia, with an area under the ROC curve of 0.86. The cut off point with the best predictive value for mortality was CURB–65 ≥ 2 points, with sensitivity 82%, specificity 83%, positive predictive value 66%, negative predictive value 92%. Conclusion: The CURB-65 is a simple and effective tool to assess the severity and prognosis in hospitalized patients with COVID-19 pneumonia.
Article Details
References
2. Ye Q, Wang B, and Mao J (2020) The pathogenesis and treatment of the `Cytokine Storm' in Covid-19. J Infect 80: 607-613.
3. Lim WS, Eerden MM, Laing R, Boersma WG, Karalus N, Town GI et al (2003) Defining community acquired pneumonia severity on presentation to hospital: An international derivation and validation study. Thorax 58: 377-382.
4. Singanayagam A and Chalmers JD (2013) Severity assessment scores to guide empirical use of antibiotics in community acquired pneumonia. Lancet Respir Med 1: 653-662.
5. Zhou F, Wang Y, Liu Y, Liu X, Gu L, Zhang X et al (2019) Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: A multicentre prospective registry study from the CAP-China Network. Eur Respir J 54.
6. Bộ Y tế (2021) Hướng dẫn chẩn đoán và điều trị Covid-19 do chủng vi rút Corona mới (SARS-CoV-2). Quyết định 3416/QĐ-BYT ngày 14/7/2021.
7. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H et al (2020) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir Med 8: 475-481.
8. Guo J, Zhou B, Zhu M, Yuan Y, Wang Q, Zhou H et al (2020) CURB-65 may serve as a useful prognostic marker in Covid-19 patients within Wuhan, China: A retrospective cohort study. Epidemiol Infect 148: 241.
9. Satici C, Demirkol MA, Sargin Altunok E, Gursoy B, Alkan M, Kamat S et al (2020) Performance of pneumonia severity index and CURB-65 in predicting 30-day mortality in patients with Covid-19. Int J Infect Dis 98: 84-89.
Article Sidebar
